Trade AbbVie ^ABBV

AbbVie (ABBV) Anticipates Strong Q1 Earnings and Robust Growth Drivers

AbbVie (ABBV) Reports Superior Efficacy of Rinvoq Over Humira in

AbbVie Inc. $ABBV Shares Sold by Vest Financial LLC

RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

AbbVie Inc. $ABBV Shares Sold by Arlington Trust Co LLC

KTF Investments LLC Makes New Investment in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Sold by Mitsubishi UFJ Trust & Banking Corp - Daily Political

AbbVie (ABBV) Maintains Dividend Strength as Core Drugs Drive Cash Flow

AbbVie Seeks FDA Approval for Subcutaneous Skyrizi (ABBV)

Is Bristol Myers Squibb the Best Bargain in Big Pharma?

AbbVie Submits Regulatory Application to FDA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease | INN

Comerica Bank Trims Stock Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by D.A. Davidson & CO.

Anchyra Partners LLC Buys Shares of 5,056 AbbVie Inc. $ABBV

Piper Sandler Cuts PT on AbbVie Inc. (ABBV) Ahead of Quarterly Results

AbbVie Inc. (ABBV) Receives CRL from the FDA About the Biologics License Application for trenibotulinumtoxinE

ABBVIE SP. Z O.O. secures contract for Pharmaceutical products

Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes

AbbVie Inc. $ABBV Shares Acquired by Vanguard Group Inc.

Top Pharmaceutical Stocks To Keep An Eye On - April 26th - Daily Political

Sanctuary Advisors LLC Buys 6,911 Shares of AbbVie Inc. $ABBV

Axecap Investments LLC Increases Stock Position in AbbVie Inc. $ABBV

Abacus FCF Advisors LLC Decreases Position in AbbVie Inc. $ABBV

Vanguard Group Inc. Purchases 3,032,438 Shares of AbbVie Inc. $ABBV - Daily Political

Richard C. Young & CO. LTD. Acquires 6,966 Shares of AbbVie Inc. $ABBV - Daily Political

10 Dividend-Paying Stocks That Retirees Will Love to Have in Their Portfolios

AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug

Calamos Advisors LLC Grows Stock Holdings in AbbVie Inc. $ABBV

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy

AbbVie's new Botox product TrenibotE stymied by FDA

AbbVie (NYSE:ABBV) Trading Down 2.3% - What's Next? - Daily Political

Procter & Gamble (PG) Reports Strong Earnings Ahead of Market Open

AbbVie Inc. $ABBV Shares Sold by Torray Investment Partners LLC

2,697 Shares in AbbVie Inc. $ABBV Bought by Wealth Science Advisors LLC - Stock Observer

Turtle Creek Wealth Advisors LLC Purchases 8,559 Shares of AbbVie Inc. $ABBV - Stock Observer

9,496 Shares in AbbVie Inc. $ABBV Purchased by Quent Long Short Global Small Cap Fund LP - Daily Political

Directional Asset Management Takes Position in AbbVie Inc. $ABBV - Daily Political

AbbVie's largest-ever capital investment of $1.4 B to build pharma manufacturing campus in US

AbbVie's US$1.4b AI-Powered Campus Reshapes Immunology And Neuroscience Story

FDA Requests Additional Information on AbbVie's Application for Neurotoxin | Morningstar

AbbVie (ABBV) Receives Complete Response Letter from FDA on Tren

Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4

These 5 Stocks Pay You Even When You're Sleeping

ABBV Maintains Overweight Rating - Price Target Lowered to $294

ABBV: Future Returns Will Rely On Immunology Expansion And Operating Leverage Execution

Pharmaceutical Stocks Worth Watching - April 23rd - Stock Observer

OLD National Bancorp IN Reduces Position in AbbVie Inc. $ABBV

Milestone Asset Management LLC Buys 19,094 Shares of AbbVie Inc. $ABBV - Markets Daily

Teacher Retirement System of Texas Has $134.75 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Stake Boosted by Milestone Asset Management LLC - Stock Observer

AbbVie (ABBV): The Best Stock to Buy on a Pullback

AbbVie to invest $1.4bn in North Carolina manufacturing campus - The Manufacturer

Does AbbVie's Durham AI Plant and Ovarian Cancer Data Reframe the Bull Case for ABBV?

Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS

AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development

AbbVie Invests $1.4 Billion in New Manufacturing Facility

Top Dividend Stocks To Add to Your Watchlist - April 22nd - Markets Daily

AbbVie building huge North Carolina manufacturing campus

AbbVie to Invest $1.4 Billion in North Carolina Manufacturing Campus | Morningstar

Should You Forget Pfizer and Buy This Pharma Stock Instead?

AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus | Morningstar

Qvr LLC Has $869,000 Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Lowered by Universal Beteiligungs und Servicegesellschaft mbH

AbbVie (NYSE:ABBV) Rating Increased to Strong-Buy at Canaccord Genuity Group

KLP Kapitalforvaltning AS Buys 29,600 Shares of AbbVie Inc. $ABBV

M&T Bank Corp Lowers Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Migdal Insurance & Financial Holdings Ltd.

TABR Capital Management LLC Purchases Shares of 47,486 AbbVie Inc. $ABBV - Stock Observer

Clarity Financial LLC Sells 23,870 Shares of AbbVie Inc. $ABBV

AbbVie (ABBV) Projected to Post Quarterly Earnings on Wednesday

Dividend Stocks To Watch Today - April 19th - Markets Daily

Assessing AbbVie (ABBV) Valuation After Recent Share Price Softness And Lofty P/E Premium

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas

Abbvie secures contract for Various medicinal products, Antineoplastic agents, Pharmaceutical products

ABBV Initiated Coverage by Canaccord Genuity -- Price Target Ann

Correction to AbbVie Article on April 20 | Morningstar

Ticino Wealth Buys New Stake in AbbVie Inc. $ABBV - Markets Daily

Private Wealth Partners LLC Sells 6,413 Shares of AbbVie Inc. $ABBV

PFG Advisors Reduces Stock Position in AbbVie Inc. $ABBV

Top 5 Dividend-Paying Stocks Yielding Over 3% for Income Investors in 2025

Top Pharmaceutical Stocks Worth Watching - April 21st - Daily Political

Ticino Wealth Acquires New Holdings in AbbVie Inc. $ABBV - Stock Observer

DSG Capital Advisors LLC Buys 5,090 Shares of AbbVie Inc. $ABBV

SageGuard Financial Group LLC Purchases New Shares in AbbVie Inc. $ABBV - Daily Political

AbbVie Announces Founding Sponsorship Of BioLabs University Of Toronto

AbbVie Weighs TrumpRx Humira Discount Against Neurology Pipeline Progress

Santen bags China rights to 5 glaucoma drugs from AbbVie

AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada

Pharmaceutical Stocks To Watch Now - April 20th - Markets Daily

AbbVie (NYSE:ABBV) Trading Down 2.1% - Here's Why - Stock Observer

Why I Can't Stop Buying AbbVie Stock

AbbVie Inc. $ABBV Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank

AbbVie Inc. $ABBV Holdings Cut by Miller Howard Investments Inc. NY